Endometrial epithelium is the presumed tissue of origin for both eutopic and endometriosis-derived clear cell and endometrioid carcinomas. We had previously hypothesized that the morphological, biological and clinical differences between these carcinomas are due to histotype-specific mutations. Although some mutations and genomic landscape features are more likely to be found in one of these histotypes, we were not able to identify a single class of mutations that was exclusively present in one histotype and not the other. This lack of genomic differences led us to an alternative hypothesis that these cancers could arise from distinct cells of origin within endometrial tissue, and that it is the cellular context that accounts for their differences. In a proteomic screen, we identified cystathionine -lyase (CTH) as a marker for clear cell carcinoma, as it is expressed at high levels in clear cell carcinomas of the ovary and endometrium. In the current study, we analysed normal Müllerian tissues, and found that CTH is expressed in ciliated cells of endometrium (both eutopic endometrium and endometriosis) and fallopian tubes. We then demonstrated that other ciliated cell markers are expressed in clear cell carcinomas, whereas endometrial secretory cell markers are expressed in endometrioid carcinomas. The same differential staining of secretory and ciliated cells was demonstrable in a three-dimensional organoid culture system, in which stem cells were stimulated to differentiate into an admixture of secretory and ciliated cells. These data suggest that endometrioid carcinomas are derived from cells of the secretory cell lineage, whereas clear cell carcinomas are derived from, or have similarities to, cells of the ciliated cell lineage.
Introduction
Ovarian cancers, and in particular ovarian carcinomas, are subdivided into histotypes that show distinct histological and clinical features [1] [2] [3] . The different properties of the histotypes can be partially explained by their histogenesis. The majority of ovarian cancers are proposed to have extraovarian origins, with the ovary providing a rich 'soil' that is permissive for the growth of cancerous cells (as reviewed in [4] ). For example, it is likely that the majority of high-grade serous carcinomas (HGSCs) of the ovary originate in fallopian tubes [5] [6] [7] . The model of HGSC pathogenesis begins with the appearance of TP53 mutation in fallopian tube secretory cells, progressing to a serous tubal intraepithelial carcinoma lesion prior to becoming invasive cancer [8] [9] [10] . The cellular origins of the other subtypes of ovarian cancer are not as well characterized.
Clear cell ovarian carcinoma (CCOC) and endometrioid ovarian carcinoma (ENOC) are both associated with ovarian endometriotic cysts, or endometriomas, which are thought to be the precursor lesions of these cancers [11] . The presence of an endometrioma increases the risk of CCOC and ENOC by up to three times [12] . Furthermore, endometriosis, both adjacent to and distant from cancer, contains mutations that are common to the associated cancer, indicating a clonal relationship [13, 14] . It is puzzling how endometriosis can give rise to two distinct histotypes of ovarian cancer; there is no single recurrent genetic mutation that is unique to either histotype. For instance, ARID1A mutations are slightly more common in CCOC, and CTTNB1 mutations arelandscape features, such as the patterns of mutations or types of genomic structural rearrangement [17] . However, the differences in the genomic landscape features between ENOC and CCOC are not absolute (see supplementary Figure 6 of [17] ); CCOC tends to have specific mutational signatures, such as the APOBEC signature, but the APOBEC signature was also found in some ENOCs. The most common feature found in the ENOC cohort was microsatellite instability (MSI); however, MSI has been described in CCOCs in other studies [18, 19] .
In an effort to further understand the differences between the three most common histotypes of ovarian cancer, we undertook a global proteomic analysis. From these studies, we identified cystathionine γ-lyase (CTH) as being highly expressed in CCOC as compared with ENOC and HGSC [20] . Here, we show that CTH is strongly expressed in ciliated cells, not only in CCOC, but also in eutopic endometrium, endometriosis, and fallopian tubes. Furthermore, this same expression pattern was observed for the ciliated cell marker ezrin. In contrast, proteins such as methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) and oestrogen receptor (ER), which are expressed at higher levels in ENOC than in CCOC, are seen in secretory (glandular) epithelial cells but not in ciliated cells. We propose that the specific ciliated or secretory cellular contexts may provide an explanation for how endometriosis gives rise to both CCOC and ENOC.
Materials and methods

Immunohistochemistry
Tissue microarrays (TMAs) were constructed with duplicate 0.6-mm cores of formalin-fixed paraffin-embedded (FFPE) materials from 29 CCOC and 30 ENOC tumours, and another TMA was constructed containing 76 endometrial endometrioid tumours. Four-micrometre sections of the TMAs or FFPE normal fallopian tube (five cases), endometrium (five cases), typical endometriosis from an endometrioma (four cases), endometriosis adjacent to CCOC (four cases), atypical endometriosis adjacent to ENOC (three cases) and endometrial clear cell carcinomas (20 
Immunofluorescence
Heat-immobilized sections (4 μm) were deparaffinized and subjected to steam heat for antigen retrieval. Slides were blocked with normal goat serum, and probed with primary antibodies as follows: anti-CTH (1:100; mouse monoclonal clone 1E12; LSBio), anti-CTH (1:50; rabbit polyclonal, LS-C312801; LSBio), anti-ezrin (1:100; rabbit polyclonal, HPA021616; Sigma), anti-ER (1:200; rabbit monoclonal, SP1; ThermoFisher), anti-FOXJ1 (1:100; mouse clone 3-19; Abcam, Cambridge, UK), and anti-MTHFD1 (1:100; rabbit polyclonal, HPA000704; Sigma). The secondary antibodies used were goat anti-mouse IgG-conjugated Alexa 594 (1:500; A11005; ThermoFisher) and goat anti-rabbit IgG-conjugated Alexa 488 (1:500; A11008; ThermoFisher). Slides were mounted in Fluorshield mounting medium containing 4 ′ ,6-diamidino-2-phenylindole (DAPI) (Sigma).
Organoid culture
Organoid culture of normal endometrium was performed with a modification of a previously described protocol for fallopian tube organoid culture [21] . A detailed protocol is shown in supplementary material, Supplementary materials and methods.
Results
+B:
CCOCs and ciliated cells share immunophenotypic features. Our previous whole proteome profiling of HGSC, ENOC and CCOC tumours demonstrated that CTH expression was higher in CCOC than in ENOC or HGSC [20] . We next investigated the expression pattern of CTH in normal Müllerian tissues by immunostaining normal endometrium (secretory phase shown) and fallopian tube ( Figure 1A) . In both tissues, CTH was very highly expressed in ciliated cells, and expressed at a much lower level in secretory cells. As endometrio expression of ezrin, a known ciliated cell marker [22] , was observed in the ciliated cells of endometrium, fallopian tube, and endometriosis, but little or no expression was seen in secretory cells ( Figure 1A ). Napsin A, a known CCOC marker [23] [24] [25] , was weakly expressed in typical endometriosis but was absent from normal endometrium and fallopian tube ( Figure 1 ). A summary of staining patterns in normal tissues is shown in Table 1 .
To verify that CTH was staining the ciliated cells and not the secretory cells of endometrium, dual immunofluorescence was performed. Dual staining of CTH and FOXJ1, a transcription factor that is specific for ciliated cells [26] , revealed that CTH and FOXJ1 stained the same cells ( Figure 1B) . Similarly, ezrin and CTH also both stained the same cells in normal endometrium ( Figure 1C ). Similar CTH, FOXJ1 and ezrin staining patterns were observed in normal fallopian tube. However, although most ciliated cells (>90%) showed co-staining of these three markers, there were some cells that expressed only one or two of them (supplementary material, Figure S1 ).
CTH was also highly expressed in atypical endometriosis adjacent to the CCOC and clear cell borderline tumour ( Figure 2 ). The same expression pattern was seen for ezrin and napsin A ( Figure 2 ). We confirmed these findings by immunostaining ENOC and CCOC for CTH (supplementary material, Figure  S2A ). We found that CTH was more highly expressed in CCOC than in ENOC (mean H-scores of 242 for CCOC and 125 for ENOC, P = 0.0001). Similarly, ezrin was more highly expressed in CCOC (mean H-scores of 205 for CCOC and 110 for ENOC, P = 0.0003; supplementary material, Figure S2B ), as was napsin A (mean H-scores of 85.2 for CCOC and 2.6 for ENOC, P < 0.0001; supplementary material, Figure S2C ). We did not observe any FOXJ1 staining in ENOC or CCOC (data not shown). The average H-scores, intensities and percentage positive cells stained are summarized in supplementary material, Table S1 .
ENOCs and secretory cells share immunophenotypic features
The observation that CCOC and ciliated cells share the expression of some proteins led us to postulate that similar expression patterns might be shared between ENOC and a different cell type, specifically secretory cells. We studied the expression of MTHFD1, a protein that is expressed at a higher level in ENOC than in CCOC in our proteomic data [20] , and ERα, which has been previously reported to be rarely expressed in CCOC [27] [28] [29] , in our ovarian cancer TMA. We found ER to be more highly expressed in ENOC than in CCOC (mean H-scores of 6.3 for CCOC and 93.5 for ENOC, P < 0.0001; Figure 3 ), as was MTHFD1 (mean H-scores of 160.3 for CCOC and 213.6 for ENOC, P = 0.031; Figure 3 ). The average H-scores, intensities and percentage positive cells stained are summarized in supplementary material, Table S1 . Both MTHFD1 and ER were expressed in normal Müllerian tissue, with their expression being much higher in secretory cells than in ciliated cells ( Figure 4A ). Both ER and MTHFD1 were expressed in the majority of the cells in endometriosis ( Figure 4A ). Examination of ENOC and adjacent endometriosis showed that ER and MTHFD1 were strongly expressed in both endometriosis and adjacent tumours ( Figure 4B ). In contrast, CTH, which was strongly expressed in endometriosis adjacent to CCOC (Figure 2) , had a weak diffuse pattern of staining in endometriosis adjacent to ENOC. Thus, the MTHFD1, ER and CTH immunostaining patterns of CCOC and ENOC are similar to what is observed in endometriosis adjacent to these same tumours.
To verify that CTH was expressed in a different cell type from MTHFD1 and ER, we performed dual immunofluorescence on normal endometrial tissue. Our results demonstrated that expression of the ciliated cell marker CTH and that of the secretory cell markers MTHFD1 and ER were mutually exclusive ( Figure 4C,  D) . Similar mutually exclusive staining patterns in the majority of cells were observed with dual immunofluorescence staining of normal fallopian tube (supplementary material, Figure S1 ).
Recapitulation of the staining patterns of CCOC and ENOC immunomarkers in the secretory and ciliated cells of organoids derived from single stem cells
We optimized growth of a three-dimensional cell culture system (organoids) derived from primary normal endometrial cells. The conditions used stimulate the endometrial stem cells to differentiate into all of the cells that are normally present in endometrium. These organoids were composed mostly of secretory cells, with occasional ciliated cells, which is similar to what we observed in normal endometrial glands ( Figure 5A ). We assessed the expression of CTH, FOXJ1 and ER in organoids by using dual immunofluorescence. The staining pattern recapitulated what was observed in normal endometrial glands ( Figure 5B ). This novel endometrium-derived organoid model system shows that endometrial stem cells can give rise to both secretory and ciliated cell types, a finding that has recently been observed by others [30] , and will allow for further characterization of the epigenetic changes that determine this lineage difference (and may contribute to the differences between CCOC and ENOC).
Finally, we examined CTH expression in clear cell carcinomas that arise in endometrium. We found that CTH stained strongly in endometrial clear cell carcinoma (in 12 of 20 cases) as compared with endometrial endometrioid cancer (in one of 76 cases; supplementary material, Figure S3 ).
Discussion
The importance of cell context in shaping both the oncogenic potential of mutations and the phenotype of resulting neoplasms is well known [4, 31, 32] . Clinical examples include the histologically and clinically diverse tumours that share ETV6-NTRK3 gene fusion [32, 33] . This concept has been recapitulated in mouse models, whereby the same mutations lead to distinct cancer phenotypes depending on which cells express the cancer mutations [34] . In a model of gynaecological cancer, the combined loss of Pten and Apc in ovarian surface epithelium leads to high-grade endometrioid-like carcinomas, whereas the same events in secretory cells in the oviduct lead to conventional low-grade endometrioid carcinomas that more accurately recapitulate the clinicopathological and immunohistochemical features of human ovarian endometrioid carcinoma [35, 36] .
To date, it is unclear how ENOC and CCOC, which are two histologically and clinically different tumours, arise from the same tissue: endometrial epithelium of ovarian endometriosis. The finding of identical mutations in ARID1A, PIK3CA and CTNNB1 in CCOC and ENOC, albeit at different frequencies in these histotypes, suggests that their clinical and phenotypic distinctions are not determined by mutation alone. Given that these mutations can also be found in deep infiltrating endometriosis, which is not a cancer precursor [37] , the ovarian microenvironment probably plays a specific role in increasing cancer risk.
In our proposed model of CCOC and ENOC pathogenesis, CCOC tumours arise from cells sharing features with ciliated cells, whereas ENOC tumours arise from secretory cells or their precursors (Figure 6 ). Central to this model is an endometrial progenitor cell, which can differentiate towards a secretory or a ciliated cell lineage, depending on cues provided from the microenvironment. In normal endometrium and in organoid culture, the secretory cell population is much more prevalent; however, a progenitor cell in an endometrioma will be exposed to different factors -haemorrhagic cyst contents, inflammation, and the ovarian stromal microenvironment -that may promote both ciliated cell differentiation and mutation en route to CCOC. Ciliated cells are presumed to be terminally differentiated [38] , so it is unlikely that mature ciliated cells within endometriosis give rise to CCOC. Instead, we posit that the cell of origin may be a cell that has committed to the ciliated cell lineage but does not yet express FOXJ1 and thus has not undergone terminal differentiation to a mature ciliated cell [22, 26, 39, 40] .
This model provides a conceptual framework to help explain the differences in the relative incidence rates of clear cell and endometrioid cancers of the ovary and endometrium. In the ovary, endometrioid and clear cell carcinomas occur with approximately equal incidence [41] , whereas, in endometrium, endometrioid carcinomas are much more common than clear cell carcinomas [42] . One explanation may be the relative ratios of cells in the ciliated and secretory lineages available to serve as cancer cells of origin in eutopic endometrium versus endometriotic cysts. Throughout the menstrual cycle, ciliated cells constitute 5-20% of endometrial epithelium [43] [44] [45] . Tubal metaplasia of endometrial glandular epithelium (an expansion of the ciliated cell population) is more prevalent in the postmenopausal period [46] , which is when the majority of endometrial clear cell cancers occur [47] . Metaplasia is often linked to chronic inflammation, and is thought to be a reprogramming of stem cells [48] ; in our proposed model, the endometrial stem cells react to microenvironmental cues in order to differentiate along different lineages.
We hypothesize that the environment in the endometriotic cyst increases the percentage of epithelial cells in the ciliated cell lineage versus eutopic endometrium. Trapped blood in the cyst leads to high levels of reactive oxygen species and inflammation [49] [50] [51] . High levels of the inflammatory cytokine interleukin (IL)-6 are present in endometriosis and CCOC [52] [53] [54] [55] , and autocrine IL-6 expressed by tumour cells (or another bypass mechanism) may be an integral step in achieving stromal independence during oncogenesis. In the trachea, IL-6 has been demonstrated to promote ciliated cell differentiation [56] . Therefore, the mutagenic effects of reactive oxygen species, together with the effects of IL-6 on inflammation and differentiation, may drive endometriotic epithelial cells into the ciliated lineage to promote CCOC. In the absence of such a differentiation switch, transformation would occur along the secretory lineage to promote ENOC. The organoid culture system described could be used to model the interplay between mutations, microenvironmental factors, and other modifiable risk factors, such as hormonal manipulation, to determine their role in differentiation and transformation. It is interesting to note that the CTH-high endometriotic epithelial cells adjacent to CCOC do not have any apparent cilia. As discussed above, we hypothesize that this is because these cells are blocked in their differentiation along the ciliated lineage prior to the point of forming mature cilia. Alternatively, they could be de-differentiated ciliated cells, secretory-type cells, or metaplastic cells. We note that PAX8 staining patterns do not support our model, as CCOC and adjacent endometriosis are positive for PAX8, a marker of Mullerian secretory epithelium. Although we cannot formally exclude the possibility that the CTH-high cells in endometriosis adjacent to CCOC may represent secretory cells, we do not favour it, as strong CTH expression is present in ciliated cells in normal endometrium and endometriosis, which do not express ER, a marker of Mullerian secretory epithelium. More importantly, if the CTH-high CCOC precursor cells were secretory (versus ciliated lineage or metaplastic cells), it would be difficult to explain why clear cell carcinoma is so rare as compared with endometrioid carcinoma in endometrium, as these secretory epithelial cells would presumably be very common in the endometrium as well.
Whereas the overlap between the expression patterns of CTH and other ciliated cell markers is absolute in endometrium, in the fallopian tube there are cells that express some markers but not others. This may be indicative of cells that are at distinct states of differentiation. In vitro modelling, e.g. with organoid cultures, will be invaluable in determining the timing of marker expression as cells differentiate along the ciliated or secretory paths. Napsin A is a marker for CCOC 34 DR Cochrane et al [23] [24] [25] . However, it is not expressed to any appreciable level in normal fallopian tube or endometrium, and has weak expression in endometriosis. It appears that some CCOC markers may give us insights into the cells of origin (CTH and ezrin), whereas others, such as napsin A, may be expressed as a consequence of mutations or other oncogenic events. Napsin A, hepatocyte nuclear factor-1β and CTH are also expressed in Arias-Stella reaction [57] (data not shown). Although Arias-Stella reaction can mimic CCOC, it is not a precursor lesion, and may indicate the plasticity of Müllerian cells in specific hormonal or stromal microenvironments.
If our model is correct, then an obvious question is why clear cell carcinomas do not occur in the fallopian tube, which is the gynaecological organ with the most ciliated cells. It is possible that the explanation goes beyond the importance of the roles of mutation and cell context, and demands consideration of the influence of particular stromal microenvironments. The fallopian tube is a highly evolved structure with two functions: (1) the transit of and nutrient support for egg and sperm; and (2) preventing implantation and ectopic pregnancy, which was frequently lethal in the presurgical era. The stroma of endometrium is distinct [58] , in that it has a key role in the maintenance and replenishment of endometrium as an ideal site for implantation, invasion, and ultimately the growth of an embryo. We therefore hypothesize that the paracrine interactions that underpin the tumour-suppressive microenvironment of the fallopian tube (not just against CCOC, but for ovarian and metastatic tumours in general) and the invasion-enhancing microenvironment of the uterus may ultimately explain the differences in the oncogenic pathways that are opened in these organ systems. This consideration may also explain why the most common subtype of 'ovarian' cancer, HGSC, which is often derived from secretory epithelial cells of the fallopian tube, presents clinically as mass lesions outside of the proposed organ of origin [4] .
Herein, we have provided correlative evidence on which to base a new model of how endometriosis-associated ovarian carcinomas develop. The model is aligned with the burgeoning recognition of the importance of cell context in shaping oncogenic opportunity [4, 31, 34] . Although functional evidence from in vitro and probably in vivo modelling of the events described here will be required to test its validity, the model offers a potential answer to one of the most vexing questions in gynaecological pathology: namely, how do two very different carcinomas with similar genetics emerge from the same precursor lesion?
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